United Therapeutics Corp (NAS:UTHR)
$ 360.87 -2.78 (-0.76%) Market Cap: 16.11 Bil Enterprise Value: 13.18 Bil PE Ratio: 15.85 PB Ratio: 2.64 GF Score: 86/100

Q2 2024 United Therapeutics Corp Earnings Call Transcript

Jul 31, 2024 / 01:00PM GMT
Release Date Price: $313.29 (-7.18%)
Operator

Good morning, everyone, and welcome to the United Therapeutics Corporation second-quarter 2024 earnings webcast. My name is Cole, and I'll be your conference operator today. (Operator Instructions) And please note that this call is being recorded. I would now like to turn the webcast over to Dewey Steadman, Head of Investor Relations, at United Therapeutics. Please go ahead.

Dewey Steadman
United Therapeutics Corp - Head of IR

Yes. Thank you, Cole. Good morning. It's my pleasure to welcome you to the United Therapeutics Corporation second-quarter 2024 earnings webcast.

Remarks we make today will include forward-looking statements representing our expectations or beliefs regarding future events. These statements involve risks and uncertainties that may cause actual results to differ materially. Our latest SEC filings, including Forms 10-K and 10-Q, contain additional information on these risks and uncertainties, and we assume no obligation to update these forward-looking statements. Remarks today may discuss the progress and results of clinical trials

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot